Status:
UNKNOWN
Evaluate the Lightening Effect of the Whitening Cosmetic Product BEX-2011
Lead Sponsor:
National Taiwan University Hospital
Collaborating Sponsors:
L'Oreal
Conditions:
Solar Lentigines
Eligibility:
FEMALE
40-65 years
Phase:
NA
Brief Summary
Background: Solar lentigines are a common dermatologic condition that manifest as circumscribed single or multiple brownish macules usually located on sun-exposed skin such as face, hands or forearms....
Detailed Description
Method: 40 subjects, who are non-gravid women between 45 to 65 years old and need to have ≥10 solar lentigines on the forearms/hands, will be recruited. One to three flat lesions which are larger than...
Eligibility Criteria
Inclusion
- 40-65 years old Asian women (skin types III to IV)
- With ≥10 solar lentigines on the forearms or dorsum of hands
- With at least one to three lesions ≥4 mm on the left or right forearm/ dorsum of hand, respectively, which are flat and are at the same pigmentation degree according to the color chart.
Exclusion
- Having major treatment, including topical hydroquinone or tretinoin, cryotherapy, electrosurgery, trichloroacetic acid application, laser or intense pulsed light, in the 3 months before the beginning of the study
- Past history of allergy to whitening cosmetic products
- Past history of atopic dermatitis
- Habit of going to the tanning salon or frequent sun exposure longer than 4 hours per day
Key Trial Info
Start Date :
June 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2011
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01249469
Start Date
June 1 2010
End Date
June 1 2011
Last Update
November 29 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Taiwan University Hospital
Taipei, Taiwan, 100